How to Use amyloid in a Sentence

amyloid

noun

• The cause of Alzheimer’s isn’t known, but amyloid is a feature of the disease.
  — The Editorial Board, WSJ, 2 Mar. 2023
• The drug targets amyloid, a protein that clumps in the brains of Alzheimer’s patients.
  — Andrew Williams, The Conversation, 14 Apr. 2022
• Some look for signs of amyloid; others, tau; still others, the ratio of the two.
  — Tribune News Service, oregonlive, 25 Nov. 2021
• That could mean a blood test to indicate the presence of amyloid.
  — Paula Span, New York Times, 4 Mar. 2024
• The drug slowed declines in both cognitive and day-to-day functions, and reduced the amount of amyloid in the brain.
  — Jason Karlawish, STAT, 6 Oct. 2022
• In this case, that was Aduhelm’s reduction of amyloid plaques.
  — Globe Staff, BostonGlobe.com, 10 Jan. 2022
• But it is thought the buildup of proteins, such as amyloid plaques and tau tangles, causes damage in the brain.
  — Will Sullivan, Smithsonian Magazine, 1 Dec. 2022
• For decades, many believed that the main cause of Alzheimer’s was a tangled clump of protein in the brain called beta-amyloid.
  — Jacob Siegal, BGR, 11 Dec. 2022
• The drug targets a sticky protein called amyloid that clumps into plaques in the brains of people with Alzheimer’s.
  — BostonGlobe.com, 8 Oct. 2021
• An intense area of study has been the use of antibodies to target amyloid plaques in the brain.
  — Greg Licholai, Forbes, 3 Oct. 2022
• Beta amyloid plaques in the brain are one of the hallmark signals of Alzheimer's, along with tangles of a protein called tau.
  — Sandee Lamotte, CNN, 23 Mar. 2022
• One of the tests was a PET scan designed to determine whether Reinstein has a buildup of amyloid in his brain.
  — Laurie McGinley, Anchorage Daily News, 4 July 2023
• Brooks said participants on the drug were allowed to switch to the placebo if the drug cleared all amyloid plaque before the end of the trial.
  — Ken Alltucker, USA TODAY, 3 May 2023
• These scans detect amyloid plaques in the brain, a telltale early sign of Alzheimer’s disease.
  — Linda Goler Blount, STAT, 26 Oct. 2022
• These three drugs work by removing beta amyloid plaques from the brain.
  — Staff Author, Verywell Health, 4 May 2023
• In Aduhelm’s case, the FDA determined amyloid levels in the brain were a reasonable proxy.
  — Allysia Finley, WSJ, 4 May 2022
• Aluminum can be found in normal healthy brains and seen within amyloid plaques.
  — Dr. Michael Daignault, USA TODAY, 14 Jan. 2022
• Plaques and fibrous tangles are formed by the proteins beta-amyloid and tau and are the hallmarks of Alzheimer’s disease.
  — Gretchen Cuda Kroen, cleveland, 18 Nov. 2022
• And this is a drug that removes a type of protein that accumulates in the brains of Alzheimer's patients called amyloid.
  — Taylor Wilson, USA TODAY, 7 July 2023
• The pileups appear to promote amyloid buildup as well as synaptic loss.
  — Dominique Mosbergen, WSJ, 22 May 2022
• Lecanemab is the latest in a long line of drugs that targets amyloid, a protein that builds up abnormally in the brains of people with Alzheimer’s.
  — Alice Park, Time, 6 Jan. 2023
• Alzheimer’s, the leading cause of dementia, characterized by a buildup of amyloid plaque and tau tangles in the brain.
  — Allysia Finley, WSJ, 5 Aug. 2021
• The patients must have had an amyloid-positive PET scan and be in good general health.
  — Julia Musto, Fox News, 16 Nov. 2021
• Leqembi works by clearing a sticky brain protein called amyloid that’s one hallmark of Alzheimer’s.
  — Matthew Perrone, Fortune, 6 Jan. 2023
• Beta amyloid is a hallmark sign of Alzheimer's disease.
  — Sandee Lamotte, CNN, 20 Oct. 2021
• To their amazement, the gamma waves cleared the mouse brains of sticky clumps of proteins called amyloid plaques, known to accumulate in Alzheimer’s patients.
  — Ryan Cross, BostonGlobe.com, 22 Mar. 2023
• The results represent the second time Alzheimer’s was slowed in a final-stage trial by a drug that clears a brain protein called amyloid.
  — Robert Langreth, BostonGlobe.com, 3 May 2023
• Unlike beta-amyloid, these gum up the inside of neurons.
  — Sara Harrison, Wired, 26 Jan. 2022
• The drug is designed to remove plaques made up of amyloid-beta proteins that build up in the brains of some people with Alzheimer’s, the most common form of dementia.
  — Jonathan Saltzman, BostonGlobe.com, 9 Aug. 2022
• The study is the latest test to a three decade old theory that Alzheimer's disease is triggered by amyloid beta plaques in the brain and can be slowed by drugs that target the buildup of those plaques.
  — Taylor Wilson, USA TODAY, 29 Sep. 2022

Last Updated: 28 May 2024